Showing results (21-30 of 33) with videos related to
Sort By:
Pageof 4
International Journal of Cancer|December 10, 2008
IL-13 cytotoxin has potent antitumor activity and synergizes with paclitaxel in a mouse model of oral squamous cell carcinomaMitomu Kioi, Takeshi Shimamura, Hideyuki Nakashima, et al.Frontiers in Immunology|April 25, 2022
Recent Advances in IL-13Rα2-Directed Cancer ImmunotherapyKarin M Knudson, SuJin Hwang, Mondona S McCann, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2002
Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapyMariko Kawakami, Koji Kawakami, Vitaly A Stepensky, et al.Journal of Translational Medicine|February 21, 2013
Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signalingBradford Hall, Hideyuki Nakashima, Zhi-Jun Sun, et al.Human Gene Therapy Methods|May 23, 2012
Specific targeting of human interleukin (IL)-13 receptor α2-positive cells with lentiviral vectors displaying IL-13Wu Ou, Michael P Marino, Akiko Suzuki, et al.Cancer Immunology, Immunotherapy : CII|December 14, 2011
Potent antitumor effects of combination therapy with IFNs and monocytes in mouse models of established human ovarian and melanoma tumorsHideyuki Nakashima, Kotaro Miyake, Christopher R Clark, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|November 17, 2018
Mechanisms for improving walking speed after longitudinal powered robotic exoskeleton training for individuals with spinal cord injuryArvind Ramanujam, Kamyar Momeni, Syed R Husain, et al.Immunotherapy|March 13, 2019
Combination immunotherapy with IL-4 Pseudomonas exotoxin and IFN-α and IFN-γ mediate antitumor effects in vitro and in a mouse model of human ovarian cancerDaniel S Green, Syed R Husain, Chase L Johnson, et al.Journal for Immunotherapy of Cancer|April 26, 2014
Regulation of immunotherapeutic products for cancer and FDA's role in product development and clinical evaluationRamjay S Vatsan, Peter F Bross, Ke Liu, et al.The Annals of Thoracic Surgery|July 28, 2004
Interleukin-4 receptor cytotoxin as therapy for human malignant pleural mesothelioma xenograftsBryce D Beseth, Robert B Cameron, Pamela Leland, et al.Pageof 4